SARMS (
Selective androgen receptor modulators) are a class of drugs that has been shown to stimulate the growth of skeletal muscle, similar to traditional anabolic steroids, but without the undesirable side effects.
Enobosarm, a
selective androgen receptor modulator, has been evaluated in 24 completed or ongoing clinical trials enrolling over 1,700 subjects, of which approximately 1,200 subjects were treated with enobosarm at doses ranging from 0.1 mg to 100 mg.
M2 EQUITYBITES-March 22, 2013-DART Therapeutics to develop selective androgen receptor modulator drug candidate(C)2013 M2 COMMUNICATIONS http://www.m2.com
DART Therapeutics, a United States-based biotechnology company, is developing a selective androgen receptor modulator drug candidate for Duchenne muscular dystrophy, a rare paediatric disease that causes genetic mutation in boys and makes them unable to make functional dystrophin, it was reported yesterday.
GLPG0492 is an orally available small molecule that Galapagos has developed in its
Selective Androgen Receptor Modulator (SARM) programme.
These updates coincided with recent FDA action to protect consumers from the potentially harmful effects of
selective androgen receptor modulators (SARMs) and highly-concentrated caffeine.
Researchers tested 44 products they bought online that were marketed as nonsteroidal
selective androgen receptor modulators (SARMs), which mimic the effect of testosterone and help build muscle.
Researchers tested 44 products they bought online that were marketed as non-steroidal
selective androgen receptor modulators (SARMs), which mimic the effect of testosterone and help build muscle.
Concerning the potential treatment for androgen-regulated diseases like benign prostatic hyperplasia and prostate cancer, several natural compounds have been recognized as agonists or antagonists against androgens [10-15], and display the tissue-selective activation of androgenic signaling [16], which are so called selective androgen receptor modulators (SARMs) by competitively binding to androgen receptor (AR).
Hough et al., "Antiandrogens act as selective androgen receptor modulators at the proteome level in prostate cancer cells," Molecular and Cellular Proteomics, vol.
